The CRUK CoL Centre Clinical Research Training Fellowship PhD Programme
Applications for CRUK CoL Centre Clinical Research Training Fellowships commencing in September 2021 are now closed. This is a unique multidisciplinary and collaborative training opportunity for any clinician who is interested in carrying out research in cancer biotherapeutics.
The fellow appointed will follow a three-year version of the CRUK CoL PhD training programme, which provides a firm foundation for clinicians with a future academic career path in mind. He/she will follow a customised training plan, developed in collaboration with their supervisors and tailored to their background and project requirements. Trainees will benefit from multi-disciplinary scientific and cohort-building activities, plus the Centre’s networking workshops and conferences.
We are looking for talented and motivated clinicians who are passionate about research, have a strong academic track record and hold full GMC registration or equivalent. These are full-time research positions with limited participation in clinical activities. They are fully funded for three years, and PhD registration will be at the primary supervisor’s university. Successful candidates will receive a salary commensurate with their current experience, paid on the clinical academic scale.
The funding for this fellowship covers students with home tuition fee status only. For more information on home tuition fee status please visit the UKCISA website. Please note that we will only be able to offer fellowships to candidates that have home tuition fee status or provide evidence that they can fund the international portion of the tuition fee from external sources (i.e. not self-funded).
Submitting your application
Applications must be submitted through the Crick’s online academic recruitment system.
Before beginning an application, you should read the information on this page and the “completing the application form” page. You should also find out about the projects being offered to start in September 2021 and their supervisors via the specific project pages (see below).
You must complete all required sections of the application form in full.
- Your application must be submitted by the deadline: 12noon, 16 November 2020.
- We will not accept late applications.
- We should receive your references by 23 November 2020. Your application may still be considered if references are not received by this deadline. However, no applicant will be invited to interview unless references have been received.
- You will find out if you have been invited to interview for the programme by 05 January 2021.
Interviews will take place remotely via zoom on the 3rd of February 2021. During the interview, candidates will be interviewed by a panel of CRUK CoL faculty. Please note that not all projects will be funded and fellowships will be awarded to the best applicants based on information submitted on the application form, references and performance during the interview.
Project 1: Using High Resolution Molecular Profiling to Decipher Upper Airway Squamous Cancer Progression. Primary Supervisor: Prof Sam Janes, Division of Medicine, University College London. Secondary Supervisor: Dr Mirjana Efremova, Barts Cancer Institute, Queen Mary University of London
Project 2: Preventing Drug Resistance to PARP inhibition in ovarian cancer through novel dosing regimens based on cancer evolutionary dynamics. Primary Supervisor: Dr Michelle Lockley. Secondary Supervisors : Dr Rowan Millar Barts Cancer Institute, Queen Mary University of London and Prof Trevor Graham, Barts Cancer Institute, Queen Mary University of London
Project 3: Imaging therapy response and mechanisms of resistance in patient-derived organoids treated with anti-tumour targeted agents ± immune checkpoint therapeutics. Primary Supervisor: Professor Tony Ng, Comprehensive Cancer Centre, King’s College London. Secondary Supervisor: Dr Martin Forster UCL Cancer Institute
Project 4: Inflamm-aging in human bone marrow and its role in evolution of clonal haematopoiesis and cancer. Primary Supervisor: Dr Elspeth Payne, UCL Cancer Institute, University College London. Secondary Supervisor: Prof Jeff Davies, Barts Cancer Institute, Queen Mary University of London
Project 5: Targeting Cancer using stromal and matrix signatures. Primary Supervisor: Dr Oliver Pearce, Barts Cancer Institute, Queen Mary University of London. Secondary Supervisor: Dr Sophie Acton MRC LMCB, University College London